NovoNordisk

SPECIALITY DRUG SUMMIT | Specialty Drug Strategies 1.0: Environment, Challenges and Employer Impacts from HHS Blueprint

Today’s employer is seeking new and innovative approaches to effectively manage specialty drugs while redefining partnerships to influence delivery system change to ensure medications are optimized and used appropriately. This summit brings together insiders and leading employers to decode the economics of specialty drugs, offer actionable and practical solutions to optimize financial and health outcomes, deliver ways to influence pharmacy benefit structures and marketplace factors that are adding to employer costs and demystify HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

In this session, we will share a brief overview of the Specialty Drug marketplace/pipeline and discuss:

  • Understand the key challenges and important strategies needed to transform pharmacy benefits
  • Identify how multiple parties in the middle are contributing to higher drug costs and what to do about it
  • Recognize key Blueprint elements and how to prepare for proposed policy changes

Leave a Reply

Your email address will not be published. Required fields are marked *